Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2021 Filed Feb 2, 2021 21:15 UTC |
Phillips Bryan KSee remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $201.51 | $0.00 |
DisclosureSEC source: 0001104659-21-010921 · a4.xml · derivative · entry 2 Phillips Bryan K · CIK 0001412895 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-01-29 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 29, 2021 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:15 UTC |
Phillips Bryan KSee remarks
|
GrantCommon Stock | 2,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-010921 · a4.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,275 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in four equal installments on each of the first through fourth anniversaries of January 29, 2021, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,289 Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:15 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 64 | $194.10 | $12,422.40 |
DisclosureSEC source: 0001104659-21-003443 · a4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:17 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 47 | $194.10 | $9,122.70 |
DisclosureSEC source: 0001104659-21-003449 · a4.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:16 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 70 | $194.10 | $13,587.00 |
DisclosureSEC source: 0001104659-21-003448 · a4.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,005 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:16 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 106 | $194.10 | $20,574.60 |
DisclosureSEC source: 0001104659-21-003447 · a4.xml · nonDerivative · entry 2 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,295 F2 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:15 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 70 | $194.10 | $13,587.00 |
DisclosureSEC source: 0001104659-21-003445 · a4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,187 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · derivative · entry 14 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,187 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · derivative · entry 13 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,067 Underlying: Common Stock · 15,000 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 50 | $187.26 | $9,363.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 300 | $186.11 | $55,833.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.04 to $186.17. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 2,508 | $185.51 | $465,259.08 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 8 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 1,522 | $184.57 | $280,915.54 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,087 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.01 to $184.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 1,374 | $183.31 | $251,867.94 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,609 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.01 to $183.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 8,326 | $182.36 | $1,518,329.36 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,983 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.01 to $182.92. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 8,760 | $181.55 | $1,590,378.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,309 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.01 to $182.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 7,347 | $180.55 | $1,326,500.85 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,069 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionCommon Stock | 15,187 | $1.14 | $17,313.18 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 40 additional shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on September 11, 2020. Read SEC document |
| December 23, 2020 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
GiftCommon Stock | 64,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 92,656 F8 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| December 23, 2020 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
GiftCommon Stock | 20,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,119 Read SEC document |
| December 23, 2020 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
GiftCommon Stock | 85,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 0 F5 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| December 17, 2020 Filed Feb 16, 2021 21:05 UTC |
NELSON MARILYN CDirector
|
GiftStock Option (right to buy) · Derivative | 4,569 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001104659-21-023904 · a5.xml · derivative · entry 2 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2029-05-02 F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 17, 2020 Filed Feb 16, 2021 21:05 UTC |
NELSON MARILYN CDirector
|
GiftStock Option (right to buy) · Derivative | 6,710 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-21-023904 · a5.xml · derivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,586 Underlying: Common Stock · Not disclosed shares Expires 2028-05-02 F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 17, 2020 Filed Mar 31, 2023 20:17 UTC |
NELSON MARILYN CDirector
|
GiftEmployee Stock Option (right to buy) · Derivative | 4,569 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001104659-23-040199 · tm2310642-1_4seq1.xml · derivative · entry 2 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,569 shares Expires 2029-05-02 F1 · kind: The option was transferred by gift disposition pursuant to an Option Transfer Agreement that was entered into consistent with the terms of the Issuer's 2018 Stock Incentive Plan, as amended. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 17, 2020 Filed Mar 31, 2023 20:17 UTC |
NELSON MARILYN CDirector
|
GiftEmployee Stock Option (right to buy) · Derivative | 6,710 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-040199 · tm2310642-1_4seq1.xml · derivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,586 Underlying: Common Stock · 6,710 shares Expires 2028-05-02 F1 · kind: The option was transferred by gift disposition pursuant to an Option Transfer Agreement that was entered into consistent with the terms of the Issuer's 2018 Stock Incentive Plan, as amended. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 1,853 | $191.76 | $355,331.28 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.11 to $192.05. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 200 | $190.53 | $38,106.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,504 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 47 | $189.36 | $8,899.92 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,704 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.11 to $189.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 800 | $188.44 | $150,752.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,751 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.01 to $188.90. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 100 | $185.00 | $18,500.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:57 UTC |
Herbert Timothy P.Director · CEO and President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 43,200 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136415 · a4.xml · derivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,200 Underlying: Common Stock · 43,200 shares Expires 2030-12-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:58 UTC |
Jandrich StevenChief Comp Off & VP, Human Res
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136416 · a4.xml · derivative · entry 2 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:56 UTC |
Ebeling PhilipChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136414 · a4.xml · derivative · entry 1 Ebeling Philip · CIK 0001662781 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:50 UTC |
Buchholz RichardChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:49 UTC |
Ban RandyChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136410 · a4.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 22:58 UTC |
Jandrich StevenChief Comp Off & VP, Human Res
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-136416 · a4.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505 Read SEC document |
| November 20, 2020 Filed Feb 16, 2021 21:05 UTC |
Herbert Timothy P.Director · CEO and President
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-023902 · a5.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 8,724 F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 331 | $173.45 | $57,411.95 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.18 to $173.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 1,929 | $172.19 | $332,154.51 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.96 to $172.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 340 | $170.46 | $57,956.40 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,911 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.42 to $170.75. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 300 | $169.09 | $50,727.00 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,251 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.9 to $169.46. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 100 | $167.36 | $16,736.00 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 474 | $165.34 | $78,371.16 |
DisclosureSEC source: 0001104659-20-123066 · a4.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 122,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.25 to $165.35. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 17,412 | $164.42 | $2,862,881.04 |
DisclosureSEC source: 0001104659-20-123066 · a4.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 123,349 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.20 to $165.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.